Ground News

Get the Full Story, Without the Noise.

Davis Enterprise image

News from Davis Enterprise

Stay current with all the latest and breaking news from Davis Enterprise. Compare headlines and media bias behind news outlets on stories breaking today.

In total, 674 have been published by Davis Enterprise which Ground News has aggregated in the past 3 months.

Ground News rates Davis Enterprise’s media bias as unknown. . Ground News is unable to assign a bias rating and does not have ratings available from Ad Fontes Media, All Sides, and Media Bias/Fact Check.

Davis Enterprise’s factuality rating is Unknown. Ground News calculates this rating using a combination of the fact and reliability ratings from Ad Fontes Media and Media Bias/Fact Check.

Information about Davis Enterprise

Where is Davis Enterprise located?Davis Enterprise's Website

Media Bias Ratings

Do you diasgree?

Edit bias

Learn more about Media Bias Ratings.

Factuality

Learn more about Factuality Ratings

Reveal Factuality Ratings by upgrading to a Premium account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Ownership

Learn more about Ownership categories

Reveal Ownership Data by upgrading to a Vantage account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Top Davis Enterprise News

Judge refuses to block move of LA Zoo elephants Billy and Tina to Tulsa Zoo

Elephants · Tulsa

Judge refuses to block move of LA Zoo elephants Billy and Tina to Tulsa Zoo

70% Center coverage: 20 sources

Amorepacific and Johns Hopkins School of Medicine's Joint Research Program 'NBRI' Participants Present Latest Findings

Baltimore, MD · Baltimore

Amorepacific and Johns Hopkins School of Medicine's Joint Research Program 'NBRI' Participants Present Latest Findings

82% Center coverage: 17 sources

Skin anti-aging and immunity effects of Amorepacific's two proprietary ingredients,See the Story

Innovent's Dual-Action Obesity Drug Takes On Semaglutide: Phase 3 Trial Reveals 73% Liver Fat Reduction

Suzhou, China · Suzhou

Innovent's Dual-Action Obesity Drug Takes On Semaglutide: Phase 3 Trial Reveals 73% Liver Fat Reduction

86% Center coverage: 15 sources

New head-to-head trial compares mazdutide vs semaglutide in 470 patients. Previous data showed 73% liver fat reduction. See full Phase 3 details.See the Story

Breaking News Topics Related to Davis Enterprise